RATIONALE: Early Life Stress (ELS) increases risk for both adult traumatization and posttraumatic stress disorder (PTSD). Adult PTSD may also reflect a continuation of a response to an earlier exposure to adversity. Given similarities between neuroendocrine aspects of PTSD and ELS, such as in reduced cortisol signaling and glucocorticoid receptor (GR) responsiveness, some aspects of the biology of PTSD may reflect biological correlates of risk. OBJECTIVES: This paper will examine how empirical findings regarding the biological basis of ELS can inform our understanding of the neuroendocrinology of PTSD. This paper will also propose a hypothetical model to guide future research that integrates genetic, epigenetic, neuroendocrine, and psychological observations to understand the contribution of ELS neurobiology to PTSD. RESULTS: Recent genetic findings demonstrate heritable aspects of at least some of these cortisol-related disturbances. Furthermore, ELS may produce at least some of the PTSD-associated changes in glucocorticoid responsiveness through epigenetic mechanisms such as developmental programming. These, then, may contribute to enduring changes in stress responsiveness as well as enhanced risk for adult exposure and PTSD. CONCLUSION: Molecular mechanisms associated with gene x environment interactions or GR programming are essential in explaining current observations in the neuroendocrinology of PTSD that have been difficult to understand through the lens of contemporary stress theory.
RATIONALE: Early Life Stress (ELS) increases risk for both adult traumatization and posttraumatic stress disorder (PTSD). Adult PTSD may also reflect a continuation of a response to an earlier exposure to adversity. Given similarities between neuroendocrine aspects of PTSD and ELS, such as in reduced cortisol signaling and glucocorticoid receptor (GR) responsiveness, some aspects of the biology of PTSD may reflect biological correlates of risk. OBJECTIVES: This paper will examine how empirical findings regarding the biological basis of ELS can inform our understanding of the neuroendocrinology of PTSD. This paper will also propose a hypothetical model to guide future research that integrates genetic, epigenetic, neuroendocrine, and psychological observations to understand the contribution of ELS neurobiology to PTSD. RESULTS: Recent genetic findings demonstrate heritable aspects of at least some of these cortisol-related disturbances. Furthermore, ELS may produce at least some of the PTSD-associated changes in glucocorticoid responsiveness through epigenetic mechanisms such as developmental programming. These, then, may contribute to enduring changes in stress responsiveness as well as enhanced risk for adult exposure and PTSD. CONCLUSION: Molecular mechanisms associated with gene x environment interactions or GR programming are essential in explaining current observations in the neuroendocrinology of PTSD that have been difficult to understand through the lens of contemporary stress theory.
Authors: Marie-Louise Meewisse; Johannes B Reitsma; Giel-Jan de Vries; Berthold P R Gersons; Miranda Olff Journal: Br J Psychiatry Date: 2007-11 Impact factor: 9.319
Authors: M L Laudenslager; R Aasal; L Adler; C L Berger; P T Montgomery; E Sandberg; L J Wahlberg; R T Wilkins; L Zweig; M L Reite Journal: Brain Behav Immun Date: 1998-03 Impact factor: 7.217
Authors: Audrey R Tyrka; Lawrence H Price; Joel Gelernter; Caroline Schepker; George M Anderson; Linda L Carpenter Journal: Biol Psychiatry Date: 2009-07-12 Impact factor: 13.382
Authors: Rebekah G Bradley; Elisabeth B Binder; Michael P Epstein; Yilang Tang; Hemu P Nair; Wei Liu; Charles F Gillespie; Tiina Berg; Mark Evces; D Jeffrey Newport; Zachary N Stowe; Christine M Heim; Charles B Nemeroff; Ann Schwartz; Joseph F Cubells; Kerry J Ressler Journal: Arch Gen Psychiatry Date: 2008-02
Authors: Jennifer A Sumner; Qixuan Chen; Andrea L Roberts; Ashley Winning; Eric B Rimm; Paola Gilsanz; M Maria Glymour; Shelley S Tworoger; Karestan C Koenen; Laura D Kubzansky Journal: Biol Psychiatry Date: 2017-06-27 Impact factor: 13.382
Authors: Richard L Hauger; J Alberto Olivares-Reyes; Frank M Dautzenberg; James B Lohr; Sandra Braun; Robert H Oakley Journal: Neuropharmacology Date: 2011-11-25 Impact factor: 5.250
Authors: Nadine M Melhem; John G Keilp; Giovanna Porta; Maria A Oquendo; Ainsley Burke; Barbara Stanley; Thomas B Cooper; J John Mann; David A Brent Journal: Neuropsychopharmacology Date: 2015-10-09 Impact factor: 7.853
Authors: Michael W Weiner; Karl E Friedl; Anthony Pacifico; Julie C Chapman; Michael S Jaffee; Deborah M Little; Geoffrey T Manley; Ann McKee; Ronald C Petersen; Roger K Pitman; Kristine Yaffe; Henrik Zetterberg; Robert Obana; Lisa J Bain; Maria C Carrillo Journal: Alzheimers Dement Date: 2013-07 Impact factor: 21.566
Authors: Carlo Faravelli; Carolina Lo Sauro; Lucia Godini; Lorenzo Lelli; Laura Benni; Francesco Pietrini; Lisa Lazzeretti; Gabriela Alina Talamba; Giulia Fioravanti; Valdo Ricca Journal: World J Psychiatry Date: 2012-02-22
Authors: K C Koenen; J A Sumner; P Gilsanz; M M Glymour; A Ratanatharathorn; E B Rimm; A L Roberts; A Winning; L D Kubzansky Journal: Psychol Med Date: 2016-10-04 Impact factor: 7.723